New Hampshire House Passes Scaled-Back Psilocybin Bill, Rejects Gun Rights Measure
New Hampshire's House recently passed a scaled-back psilocybin bill reflecting evolving psilocybin policy developments. These legislative changes create regulatory uncertainty impacting clinical planning and patient access. Clinicians should monitor…
Mental Health Problems More Likely for Teen Cannabis Users
Adolescent cannabis mental health studies show increased psychiatric risks for teen cannabis users. These studies highlight the vulnerability of the developing brain to cannabis exposure. Clinicians should screen for cannabis use alongside mental health…
Lawmakers Debate Regulation of Psychedelic Clinical Trials
Legislative frameworks are shaping the regulation of psychedelic clinical trials, impacting patient access to emerging therapies. As FDA approval processes progress for psilocybin and MDMA, lawmakers debate safety and training protocols. Psychedelic…
Understanding Substance Use Referrals Among Psychiatric Inpatients
Substance use referrals among inpatients with serious mental illness are critical for integrated treatment. This study highlights referral patterns in psychiatric settings. Understanding these referrals helps optimize care for dual diagnosis patients.
Hobart City Council to Deploy Safety Liaison Officers Amid Antisocial Rise
Hobart City Council is implementing public safety initiatives urban areas by introducing safety liaison officers to address rising antisocial behaviour. These officers aim to manage community safety with a focus on mental health and substance use.…
Survey: More than half of Washington clinicians cite mental-health risks from cannabis use
A recent survey highlights mental health cannabis risks as cited by over half of Washington clinicians. This reflects a gap in clinical cannabis risk assessment education. Understanding these mental health cannabis risks is essential for informed patient…
Study: Cannabis Harm Reduction Strategies
This 2025 review maps cannabis harm reduction strategies across legal, social, and health-related domains, from packaging rules and driving policies to cannabis social clubs and product testing. It is useful as a typology and policy overview, but it does…
Cannabis Use Disorder Treatment Europe Review
CED Clinical Relevance #50 Monitored Relevance Early-stage or contextual signal requiring further evidence before action. Clinical Insight | CED Clinic Evidence Watch Cannabis Use Disorder Europe Mental Health Audience Patients, caregivers,…
West-Asia War Impact: IDF Strikes and Psychological Stress
Military conflicts and psychological stress significantly impact mental health, especially PTSD and anxiety. Cannabis medicine may help manage acute stress responses during such events. Understanding this relationship is crucial for vulnerable…
There Are No Positives for Young Adult Cannabis Users | Psychology Today
Young adult cannabis use risks are significant due to ongoing brain development until around age 25. Cannabis affects executive function, memory, and emotional regulation in this group. Clinicians should focus on harm reduction strategies tailored to…
